A continuaciónSiguiente guía
AI Target Identification in Drug Discovery
Industrias
GUÍA de industrias
AI methods can support several stages of drug research, including protein-structure prediction, molecular property prediction, virtual screening and molecule generation.
Escuche esta guíaNarrado por IA · ~2 min
A model result is a research hypothesis or prioritization signal, not evidence of clinical safety or efficacy.
AlphaFold predicts protein structures, while AlphaFold 3 extends structure prediction to biomolecular complexes involving proteins, nucleic acids, small molecules and other components. MoleculeNet describes machine-learning tasks over molecular representations including graphs and SMILES. Deep Docking illustrates one virtual-screening approach that uses predictions to reduce how many compounds require expensive docking calculations. DeepTox and later molecular-generation studies address toxicity prediction and candidate generation; these methods do not establish a compound’s safety, efficacy or clinical success. FDA describes preclinical testing and an IND process before clinical studies in people.
Using AlphaFold to predict protein structures, as reported in its paper and resource database.
Using AlphaFold 3 to predict structures and interactions among proteins, nucleic acids, small molecules and other biomolecules.
Representing molecules as graphs or SMILES strings in molecular-learning benchmarks.
Using virtual screening to prioritize compounds for experimental testing, with predictions treated as uncertain.
Evaluate screening and generation methods on prospective, target-relevant data and report experimental confirmation rates. Follow regulatory requirements for preclinical and human research; remove candidates only after evidence appropriate to the task, rather than treating model scores as final decisions.
Boletín gratuito
Tres noticias verificadas sobre IA cada mañana de lunes a viernes, explicadas con claridad. Gratis para siempre y sin anuncios.
Un correo cada día laborable. Date de baja con un clic. Nunca vendemos ni compartimos tu dirección.
Ponte a prueba
Corrección inmediata en cada respuesta y un certificado para compartir, con un ID verificable, cuando apruebas un curso.
Apoya la educación gratuita sobre IA. AI Understanding es una organización sin fines de lucro 501(c)(3): sin anuncios ni muros de pago, nunca. Hacer una donación
AI methods can support several stages of drug research, including protein-structure prediction, molecular property prediction, virtual screening and molecule generation. A model result is a research hypothesis or prioritization signal, not evidence of clinical safety or efficacy.
AlphaFold utilizó el aprendizaje profundo para predecir estructuras 3D de proteínas a escala, brindando a los investigadores planos estructurales que anteriormente requerían años de experimentos.
Las moléculas son naturalmente gráficos (átomos = nodos, enlaces = bordes) procesados por redes neuronales de gráficos o codificados como cadenas SMILES para modelos de secuencia.
La evaluación virtual utiliza modelos para calificar enormes bibliotecas de moléculas in silico, por lo que solo se crean y prueban en el laboratorio los mejores candidatos.
Computational ADME/toxicity predictions can prioritize compounds for follow-up; they are model outputs and do not establish safety or replace experimental testing.
Los modelos generativos como VAE y modelos de difusión toman muestras de nuevas estructuras a partir de un espacio químico aprendido, optimizando las propiedades deseadas.
sigue aprendiendo
Más guías seleccionadas para este tema.
A continuaciónSiguiente guía
AI Target Identification in Drug Discovery
Industrias